Science and Technology Department (Commission), Health and Family Planning Commission, and Food and Drug Administration in Beijing, Shanghai, Sichuan Province, Shanxi Province and Hunan Province

It is hereby notified that in order to strengthen scientific and technological innovation in medicine, optimize mode of clinical trials, accelerate the breakthrough of prevention and control technology in serious diseases, and improve application of the medical achievements transformation, the Ministry of Science and Technology, National Health and Family Planning Commission, Logistical Support Department of CMC, and CFDA have worked together to review the 3rd batch of National Clinical Medicine Research Center. Then the list of the 3rd batch of National Clinical Medicine Research Center is approved and issued (refer to the attachment for list of support units). 

In accordance with the relevant requirements of Regulations on National Clinical Medicine Research Center (Trial), departments in charge and all support units of National Clinical Medicine Research Center shall organize and administer earnestly. 

Appendix: the list of the 3rd batch of support units of National Clinical Medicine Research Center

 Ministry of Science and Technology, National Health and Family Planning Commission, Logistical Support Department of CMC, CFDA 

July 18, 2016

Appendix:

 List of the 3rd Batch of Support Units of National Clinical Medicine Research Center